Identification of peptide products from enzymatic degradation of amyloid beta

Biochimie

Volumn 105, Issue , 2014, Pages 216-220

  Rogeberg, Magnus ^a   Furlund, Camilla B ^a   Moe, Morten K ^a   Fladby, Tormod ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

Alzheimer's disease; Amyloid beta; Enzymatic degradation; Liquid chromatography mass spectrometry

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; PEPTIDE; PROTEIN HYDROLYSATE; AMYLOID BETA PROTEIN; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; ENZYMATIC DEGRADATION; ENZYME DEGRADATION; HUMAN; HYDROLYSIS; IN VITRO STUDY; INCUBATION TIME; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; BRAIN; CHEMISTRY; METABOLISM; PATHOLOGY; PROTEIN DEGRADATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BRAIN; CHROMATOGRAPHY, LIQUID; HUMANS; HYDROLYSIS; MASS SPECTROMETRY; PEPTIDE FRAGMENTS; PROTEOLYSIS;

EID: 84907817648     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2014.06.023     Document Type: Article

References (34)

1. C. Haass, C. Kaether, G. Thinakaran, and S. Sisodia Trafficking and proteolytic processing of APP Cold Spring Harb. Perspect. Med. 2 2012 a006270
2. T. Saido, and M.A. Leissring Proteolytic degradation of amyloid β-protein Cold Spring Harb. Perspect. Med. 2 2012 a006379
3. D.-S. Wang, D.W. Dickson, and J.S. Malter β-Amyloid degradation and Alzheimer's disease Biomed. Res. Int. 2006 2006
4. S. Chimon, M.A. Shaibat, C.R. Jones, D.C. Calero, B. Aizezi, and Y. Ishii Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid Nat. Struct. Mol. Biol. 14 2007 1157 1164
5. P. Hortschansky, V. Schroeckh, T. Christopeit, G. Zandomeneghi, and M. Fändrich The aggregation kinetics of Alzheimer's β-amyloid peptide is controlled by stochastic nucleation Protein Sci. 14 2005 1753 1759
6. E. Hellstrand, B. Boland, D.M. Walsh, and S. Linse Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process ACS Chem. Neurosci. 1 2009 13 18
7. K. Ono, M.M. Condron, and D.B. Teplow Structure-neurotoxicity relationships of amyloid β-protein oligomers Proc. Natl. Acad. Sci. U.S.A. 106 2009 14745 14750
8. W.M. Kok, J.M. Cottam, G.D. Ciccotosto, L.A. Miles, J.A. Karas, D.B. Scanlon, B.R. Roberts, M.W. Parker, R. Cappai, K.J. Barnham, and C.A. Hutton Synthetic dityrosine-linked [small beta]-amyloid dimers form stable, soluble, neurotoxic oligomers Chem. Sci. 4 2013 4449 4454
9. G.M. Shankar, S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, I. Smith, F.M. Brett, M.A. Farrell, M.J. Rowan, C.A. Lemere, C.M. Regan, D.M. Walsh, B.L. Sabatini, and D.J. Selkoe Amyloid-[beta] protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat. Med. 14 2008 837 842
10. W. Farris, S.G. Schütz, J.R. Cirrito, G.M. Shankar, X. Sun, A. George, M.A. Leissring, D.M. Walsh, W.Q. Qiu, D.M. Holtzman, and D.J. Selkoe Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy Am. J. Pathol. 171 2007 241 251
11. N. Iwata, S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, N.P. Gerard, C. Gerard, E. Hama, H.-J. Lee, and T.C. Saido Metabolic regulation of brain Aβ by neprilysin Science 292 2001 1550 1552
12. J. Pacheco-Quinto, and E.A. Eckman Endothelin-converting enzymes degrade intracellular β-amyloid produced within the endosomal/lysosomal pathway and autophagosomes J. Biol. Chem. 288 2013 5606 5615
13. E.A. Eckman, M. Watson, L. Marlow, K. Sambamurti, and C.B. Eckman Alzheimer's disease β-amyloid peptide is increased in mice deficient in endothelin-converting enzyme J. Biol. Chem. 278 2003 2081 2084
14. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, M.P. Frosch, C.B. Eckman, R.E. Tanzi, D.J. Selkoe, and S. Guenette Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo Proc. Natl. Acad. Sci. U.S.A. 100 2003 4162 4167
15. M.A. Leissring, W. Farris, A.Y. Chang, D.M. Walsh, X. Wu, X. Sun, M.P. Frosch, and D.J. Selkoe Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death Neuron 40 2003 1087 1093
16. N. Iwata, H. Mizukami, K. Shirotani, Y. Takaki, S.-i. Muramatsu, B. Lu, N.P. Gerard, C. Gerard, K. Ozawa, and T.C. Saido Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-β peptide in mouse brain J. Neurosci. 24 2004 991 998
17. S. Howell, J. Nalbantoglu, and P. Crine Neutral endopeptidase can hydrolyze β-amyloid(1-40) but shows no effect on β-amyloid precursor protein metabolism Peptides 16 1995 647 652
18. A. Mukherjee, E.-s. Song, M. Kihiko-Ehmann, J.P. Goodman, J.S. Pyrek, S. Estus, and L.B. Hersh Insulysin hydrolyzes amyloid β peptides to products that are neither neurotoxic nor deposit on amyloid plaques J. Neurosci. 20 2000 8745 8749
19. G. Sadik, H. Kaji, K. Takeda, F. Yamagata, Y. Kameoka, K. Hashimoto, K. Miyanaga, and T. Shinoda In vitro processing of amyloid precursor protein by cathepsin D Int. J. Biochem. Cell Biol. 31 1999 1327 1337
20. E.A. Eckman, D.K. Reed, and C.B. Eckman Degradation of the Alzheimer's amyloid β peptide by endothelin-converting enzyme J. Biol. Chem. 276 2001 24540 24548
21. M.A. Leissring, A. Lu, M.M. Condron, D.B. Teplow, R.L. Stein, W. Farris, and D.J. Selkoe Kinetics of amyloid β-protein degradation determined by novel fluorescence- and fluorescence polarization-based assays J. Biol. Chem. 278 2003 37314 37320
22. Q. Guo, M. Manolopoulou, Y. Bian, A.B. Schilling, and W.-J. Tang Molecular basis for the recognition and cleavages of IGF-II, TGF-α, and amylin by human insulin-degrading enzyme J. Mol. Biol. 395 2010 430 443
23. D. Arnold, W. Keilholz, H. Schild, T. Dumrese, S. Stevanović, and H.-G. Rammensee Substrate specificity of cathepsins D and E determined by N-terminal and C-terminal sequencing of peptide pools Eur. J. Biochem 249 1997 171 179
24. H. Sun, X. Lou, Q. Shan, J. Zhang, X. Zhu, J. Zhang, Y. Wang, Y. Xie, N. Xu, and S. Liu Proteolytic characteristics of cathepsin D related to the recognition and cleavage of its target proteins PLoS one 8 2013 e65733
25. Y. Shen, A. Joachimiak, M. Rich Rosner, and W.-J. Tang Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism Nature 443 2006 870 874
26. M. Manolopoulou, Q. Guo, E. Malito, A.B. Schilling, and W.-J. Tang Molecular basis of catalytic chamber-assisted unfolding and cleavage of human insulin by human insulin-degrading enzyme J. Biol. Chem. 284 2009 14177 14188
27. I.V. Kurochkin Insulin-degrading enzyme: embarking on amyloid destruction Trends Biochem. Sci. 26 2001 421 425
28. G.D. Johnson, H.R. Swenson, R. Ramage, and K. Ahn Mapping the active site of endothelin-converting enzyme-1 through subsite specificity and mutagenesis studies: a comparison with neprilysin Arch. Biochem. Biophys. 398 2002 240 248
29. L.B. Hersh, and K. Morihara Comparison of the subsite specificity of the mammalian neutral endopeptidase 24.11 (enkephalinase) to the bacterial neutral endopeptidase thermolysin J. Biol. Chem. 261 1986 6433 6437
30. C. Oefner, A. D'Arcy, M. Hennig, F.K. Winkler, and G.E. Dale Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon J. Mol. Biol. 296 2000 341 349
31. W.J. Meilandt, M. Cisse, K. Ho, T. Wu, L.A. Esposito, K. Scearce-Levie, I.H. Cheng, G.-Q. Yu, and L. Mucke Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Aβ oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice J. Neurosci. 29 2009 1977 1986
32. A. Halim, G. Brinkmalm, U. Ruetschi, A. Westman-Brinkmalm, E. Portelius, H. Zetterberg, K. Blennow, G. Larson, and J. Nilsson Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid β-peptides in human cerebrospinal fluid Proc. Natl. Acad. Sci. U.S.A. 108 2011 11848 11853
33. G. Brinkmalm, E. Portelius, A. Öhrfelt, N. Mattsson, R. Persson, M.K. Gustavsson, C.H. Vite, J. Gobom, J.E. Månsson, and J. Nilsson An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid J. Mass. Spectrom. 47 2012 591 603
34. Z. Liu, H. Zhu, G.G. Fang, K. Walsh, M. Mwamburi, B. Wolozin, S.O. Abdul-Hay, T. Ikezu, M.A. Leissring, and W.Q. Qiu Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: a role in Alzheimer's disease? J. Alzheimers Dis. 29 2012 329 340